Annual evolution of the prescription of drugs with prognostic implications in acute decompensated heart failure with reduced ejection fraction

Abstract Background Quadruple therapy (renin angiotensin system inhibitors, beta-blockers, mineralocorticoid receptor antagonists and sodium/glucose cotransporter type 2 inhibitors [SGLT2i]) has become the current prognostic modifying treatment for heart failure (HF) with reduced ejection fraction (...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Raquel López-Vilella, Víctor DonosoTrenado, Borja Guerrero Cervera, Ignacio Sánchez-Lázaro, Luis Martínez Dolz, Luis Almenar Bonet
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2024-02-01
Serie:	BMC Cardiovascular Disorders
Soggetti:	Quadruple therapy Acute heart failure Heart failure subgroups Prescription Evolution
Accesso online:	https://doi.org/10.1186/s12872-024-03728-y
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!